Koninklijke DSM N.V

Company Profile

Koninklijke DSM N.V had its IPO on under the ticker symbol KDSKF.

The company operates in the Basic Materials sector and Specialty Chemicals industry. Koninklijke DSM N.V has a staff strength of 19,263 employees.

Stock update

Shares of Koninklijke DSM N.V opened at $82 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $82 - $82, and closed at $82.

This is a +17.14% increase from the previous day's closing price.

A total volume of 2 shares were traded at the close of the day’s session.

In the last one week, shares of Koninklijke DSM N.V have increased by +17.14%.

Koninklijke DSM N.V's Key Ratios

Koninklijke DSM N.V has a market cap of $468.75 million, indicating a price to book ratio of 2.1203 and a price to sales ratio of 2.2674.

In the last 12-months Koninklijke DSM N.V’s revenue was $8.39 billion with a gross profit of $2.69 billion and an EBITDA of $1.23 billion. The EBITDA ratio measures Koninklijke DSM N.V's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Koninklijke DSM N.V’s operating margin was 7.77% while its return on assets stood at 2.44% with a return of equity of 4.69%.

In Q2, Koninklijke DSM N.V’s quarterly earnings growth was a positive 87.5% while revenue growth was a negative 9.4%.

Koninklijke DSM N.V’s PE and PEG Ratio

Forward PE

29.4985

Trailing PE

10.4322

PEG

2.8825

Its diluted EPS in the last 12-months stands at $6.71 per share while it has a forward price to earnings multiple of 29.4985 and a PEG multiple of 2.8825. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Koninklijke DSM N.V’s profitability.

Koninklijke DSM N.V stock is trading at a EV to sales ratio of 2.3847 and a EV to EBITDA ratio of 22.7164. Its price to sales ratio in the trailing 12-months stood at 2.2674.

Koninklijke DSM N.V stock pays annual dividends of $2.53 per share, indicating a yield of 2.25% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$16.85 billion

Total Liabilities

$3.02 billion

Operating Cash Flow

$-323000000.00

Capital Expenditure

$149.50 million

Dividend Payout Ratio

0%

Koninklijke DSM N.V ended 2024 with $16.85 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $16.85 billion while shareholder equity stood at $9.73 billion.

Koninklijke DSM N.V ended 2024 with $0 in deferred long-term liabilities, $3.02 billion in other current liabilities, 328000000.00 in common stock, $8.55 billion in retained earnings and $0 in goodwill. Its cash balance stood at $792.00 million and cash and short-term investments were $1.63 billion. The company’s total short-term debt was $98,000,000 while long-term debt stood at $0.

Koninklijke DSM N.V’s total current assets stands at $7.58 billion while long-term investments were $0 and short-term investments were $838.00 million. Its net receivables were $1.77 billion compared to accounts payable of $1.54 billion and inventory worth $2.39 billion.

In 2024, Koninklijke DSM N.V's operating cash flow was $-323000000.00 while its capital expenditure stood at $149.50 million.

Comparatively, Koninklijke DSM N.V paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$82

52-Week High

$160

52-Week Low

$32.05

Analyst Target Price

$

Koninklijke DSM N.V stock is currently trading at $82 per share. It touched a 52-week high of $160 and a 52-week low of $160. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $78.08 and 200-day moving average was $114.33 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 36738.5% are held by institutions.